Brimonidine
Sponsors
Region Vaesterbotten, Hiroshima Uiversity, Allergan, Medical University of Vienna, Federal University of São Paulo
Conditions
Diabetic RetinopathyDry EyeEye DiseasesGlaucomaIntraocular PressureIntraocular Pressure Change in Intravitreal InjectionMacular DegenerationMacular Edema
Early Phase 1
Phase 2
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab
CompletedNCT00804921
Updated: 2008-12-09
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
NCT01345448
Start: 2011-04-30End: 2011-07-31Target: 22Updated: 2011-05-02
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
CompletedNCT01726075
Start: 2013-02-28End: 2015-11-30Updated: 2016-01-12
Dry Eye Disease Study With Brimonidine
CompletedNCT03418727
Start: 2017-09-06End: 2018-03-29Updated: 2022-07-06
Phase 3
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
CompletedNCT00168363
Start: 2005-01-31End: 2006-08-31Updated: 2011-05-30
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
CompletedNCT02289352
Start: 2014-07-31End: 2014-12-31Updated: 2020-01-14
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
CompletedNCT05656027
Start: 2022-12-19End: 2024-01-25Updated: 2026-02-25
Phase 4
Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
CompletedNCT00312416
Start: 2004-02-29End: 2004-12-31Target: 18Updated: 2007-02-12
INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE
TerminatedNCT00347035
Updated: 2006-10-26
Brimonidine vs ALTP in Progressing Human Glaucoma
CompletedNCT00466479
Start: 1999-08-31End: 2002-10-31Target: 50Updated: 2007-04-27
Mirvaso in Use Study
CompletedNCT02249065
Start: 2014-09-30End: 2015-08-31Updated: 2022-08-01
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
CompletedNCT02761174
Start: 2016-03-13End: 2017-01-13Updated: 2018-01-05
The Effect of Brimonidine
CompletedNCT03959176
Start: 2019-07-20End: 2019-07-20Updated: 2024-02-01
Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma
Active, not recruitingCTIS2023-510041-16-00
Start: 2013-04-22Target: 240Updated: 2024-05-16
Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
CompletedNCT06449352
Start: 2024-06-13End: 2025-09-22Updated: 2025-10-22
Unknown Phase
Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature
CompletedNCT01201551
Start: 2011-06-30End: 2013-11-30Updated: 2013-12-11
Efficacy of brimonidine for transient IOP rise after cataract surgery
Active, not recruitingJPRN-UMIN000011691
Start: 2013-09-15Target: 50Updated: 2025-07-18
Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection
CompletedNCT02140450
Start: 2012-02-29End: 2014-05-31Updated: 2014-05-16